These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38391922)

  • 1. Taming Microglia in Alzheimer's Disease: Exploring Potential Implications of Choline Alphoscerate via α7 nAChR Modulation.
    Cantone AF; Burgaletto C; Di Benedetto G; Pannaccione A; Secondo A; Bellanca CM; Augello E; Munafò A; Tarro P; Bernardini R; Cantarella G
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial Effects of Choline Alphoscerate on Amyloid-β Neurotoxicity in an In vitro Model of Alzheimer's Disease.
    Burgaletto C; Di Benedetto G; Munafò A; Bernardini R; Cantarella G
    Curr Alzheimer Res; 2021; 18(4):298-309. PubMed ID: 34102970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models.
    Matsumura A; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Takata K; Kitamura Y; Shimohama S
    J Alzheimers Dis; 2015; 44(2):409-23. PubMed ID: 25352454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
    Shen J; Wu J
    Int Rev Neurobiol; 2015; 124():275-92. PubMed ID: 26472533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Alpha-7-Nicotinic Acetylcholine Receptor in Alzheimer's Disease.
    Singh S; Agrawal N; Goyal A
    CNS Neurol Disord Drug Targets; 2024; 23(3):384-394. PubMed ID: 37366362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
    Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E
    Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
    Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
    J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
    Ni R; Marutle A; Nordberg A
    J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression levels of the α7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells.
    Ren JM; Zhang SL; Wang XL; Guan ZZ; Qi XL
    Mol Med Rep; 2020 Sep; 22(3):2063-2075. PubMed ID: 32582986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?
    Hernandez CM; Dineley KT
    Curr Drug Targets; 2012 May; 13(5):613-22. PubMed ID: 22300028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors.
    Takata K; Kitamura Y; Saeki M; Terada M; Kagitani S; Kitamura R; Fujikawa Y; Maelicke A; Tomimoto H; Taniguchi T; Shimohama S
    J Biol Chem; 2010 Dec; 285(51):40180-91. PubMed ID: 20947502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer's Disease Mice.
    Fonar G; Polis B; Sams DS; Levi A; Malka A; Bal N; Maltsev A; Elliott E; Samson AO
    Mol Neurobiol; 2021 May; 58(5):2322-2341. PubMed ID: 33417228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective and Neurotoxic Implications of α7 Nicotinic Acetylcholine Receptor and Aβ Interaction: Therapeutic Options in Alzheimer's Disease.
    Farhat SM; Ahmed T
    Curr Drug Targets; 2017; 18(13):1537-1544. PubMed ID: 27719660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking mPTP on Neural Stem Cells and Activating the Nicotinic Acetylcholine Receptor α7 Subunit on Microglia Attenuate Aβ-Induced Neurotoxicity on Neural Stem Cells.
    Chen Q; Wang K; Jiang D; Wang Y; Xiao X; Zhu N; Li M; Jia S; Wang Y
    Neurochem Res; 2016 Jun; 41(6):1483-95. PubMed ID: 26875732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease.
    Ma KG; Qian YH
    Neuropeptides; 2019 Feb; 73():96-106. PubMed ID: 30579679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
    Kroker KS; Moreth J; Kussmaul L; Rast G; Rosenbrock H
    Brain Res Bull; 2013 Jul; 96():28-38. PubMed ID: 23639920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity.
    Liu Q; Xie X; Emadi S; Sierks MR; Wu J
    Neuropharmacology; 2015 Oct; 97():457-63. PubMed ID: 25959067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.
    Nakaizumi K; Ouchi Y; Terada T; Yoshikawa E; Kakimoto A; Isobe T; Bunai T; Yokokura M; Suzuki K; Magata Y
    J Alzheimers Dis; 2018; 61(4):1355-1365. PubMed ID: 29376856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases.
    Kawamata J; Shimohama S
    J Alzheimers Dis; 2011; 24 Suppl 2():95-109. PubMed ID: 21403387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen-activated protein kinase signaling pathways are involved in regulating α7 nicotinic acetylcholine receptor-mediated amyloid-β uptake in SH-SY5Y cells.
    Yang WN; Ma KG; Chen XL; Shi LL; Bu G; Hu XD; Han H; Liu Y; Qian YH
    Neuroscience; 2014 Oct; 278():276-90. PubMed ID: 25168732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.